Please provide your email address to receive an email when new articles are posted on . Within the studied cohort, males had a higher IPF death rate than females. Researchers observed eight industries ...
NASHVILLE, Tenn. (WTVF) — Could your job be slowly killing you? The CDC says new studies show those who work certain jobs, or in specific industries, could be more likely to develop a deadly lung ...
Delayed IPF diagnosis often results in significant lung function impairment, impacting patient outcomes and increasing hospitalization rates. Antifibrotic therapies, nintedanib and pirfenidone, are ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. There are only three therapies for IPF approved by the ...
VANCOUVER, British Columbia, March 30, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical ...
15d
JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment
Not intended for UK and US audiences JASCAYD® (nerandomilast) now approved by Japan’s MHLW for the treatment of adults with idiopathic pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results